2017 ISEH Journal Club: Q&A with Jeff Bernitz
The New Investigators Committee is
excited to announce a new ISEH Journal Club for 2017. We will be starting with
an exciting publication by Jeff Bernitz, Kateri Moore and colleagues, entitled Hematopoietic
Stem Cells Count and Remember Self-Renewal Divisions, recently published in CELL.
This first ISEH Journal Club will run
23rd-30th January. During this time, Jeff Bernitz will be
answering any questions you have about the paper on the ISEH Facebook page. Please join the ISEH Facebook group, post your questions and
join the discussion!
To help introduce this paper and start
the discussion, we conducted a Q&A with paper’s first author, Jeff Bernitz.
Jeff is a current PhD student with Kateri Moore at the Icahn School of Medicine at Mount Sinai.
Question 1. What are the key findings
of your paper?
Jeff: I
think there were several key findings in the paper, but in the end these can be
boiled down to two. The first is that cells within the HSC compartment are
capable of maintaining a record of their divisional history, and this impacts
on both their future regenerative potential and cell cycle progression. This
memory also appears to instruct how HSCs accumulate with age. The second is
that the stem cell compartment is heterogeneous, with the minority of these
cells possessing LT-HSC function, and this is especially true when considering
the aging HSC compartment. I think this is something that the field already
knew, but what is nice about our work is that we were able to show that this
functional heterogeneity can be correlated to divisional history.
Question 2. What was the motivation for
this line of research?
Jeff: I
wish I could say that there was a direct line of logic that motivated the work,
but the truth is the study came together largely out of serendipity. A previous
graduate student in the lab had placed 30-40 of our label-retaining mice on
doxycycline, but never analyzed the mice before she left. This left us with
several cages of mice that had been on dox for 9-12 months by the time I
started. When I came into the lab I initially didn't have a project, so my
first task was to analyze some of these mice that had been on dox for over a
year just to see if we could find any label-retaining cells left in the HSC
compartment. Of course, we were surprised when we found label-retaining cells
after a year on dox, so we started doing transplants and the study slowly began
to evolve and reveal itself to us from there.
Question 3. In your opinion, how will
your story impact the blood field? What new questions does it open up?
Jeff: I
hope the story will get people to begin considering how divisional history may
play a role in defects associated with drug treatments, stress, and (in our
case) aging. I also think that a major implication of our work may extend to
understanding HSC expansion for clinical use. The field has been attempting to
expand stem cells ex vivo for decades, but has been largely unsuccessful. I
think our work provides clues as to why these efforts have not worked:
divisional history directly relates to HSC regenerative potential, and the more
a cell divides the less regenerative potential it contains. Thus simply forcing
HSCs to “self-renew” may not be possible. Obviously this opens a Pandora’s box
of questions on how HSCs maintain their divisional history counter, and by
extension how we can reset this memory to aid in expanding HSCs without
sacrificing function.
Question 4. Are there members of our
ISEH community that contributed to the context for your paper? How did he/she
contribute to your research question?
Jeff: Yes,
there are several. Isabel Beerman and Derrick Rossi demonstrated nicely that
increasing HSC divisional history via serial 5-FU injections induces several
cellular and molecular changes associated with aging HSCs. This work was
followed up on by Dagmar Walter and Amelie Lier from Michael Milsom’s group,
where they demonstrate serial rounds of pI:pC induced proliferative stress
leads to DNA damage accumulation in HSCs, which in the context of Fanca-/-
mice results in a premature aging phenotype associated with Fanca mutations in
humans. Together, these studies showed that the accumulation of divisional
history may underlie several defects associated with HSC aging. Additionally,
Ryo Yamamoto and Hiromitsu Nakauchi showed that the phenotypically identifiable
HSC compartment contains cells that, upon transplantation, only generate
myeloid cells. This work directly inspired our limiting dilution
transplantation studies in the paper. As it is known that myeloid output from
the HSC compartment increases with age we wanted to see if this was in part due
to an over-representation of myeloid-restricted progenitors, and whether these
cells correlated with an extensive divisional history.
Question 5. Who would you particularly
like to read your paper?
Jeff: If I could have anyone read the paper, that person would be Christa
Muller-Sieburg. I worked in Christa’s lab as an intern during undergrad, and my
time in her lab heavily influenced how I view and interpret HSC research. In
some ways I feel this directly contributed to how our paper came together. Her
husband, Hans Sieburg, collaborated with us on this work, and both Teri and I
view the paper as the culmination of my time and experiences between the two
labs. Christa had one of the most beautiful minds I’ve ever seen. When we had journal
club and lab meeting, she would pick out flaws in logic and reason that no one
else perceived. She was sharp as a knife. I would particularly like her to read
the paper, in part, because I know she would shred it to pieces – which can be
devastating, but in the end I think this makes us better critical thinkers and
scientists. Though more than anything, I just hope that the work would make her
proud.
Thank you to Jeff Bernitz for kicking off our 2017 ISEH Journal Club. Please visit the ISEH Facebook page from 23rd-30th January to submit your questions and join the discussion.
Adam Wilkinson, PhD
ISEH New Investigators Committee Member
Postdoctoral Research Fellow
Institute of Stem Cell Biology and Regenerative Medicine
Institute of Stem Cell Biology and Regenerative Medicine
Stanford Medicine
CA, USA
Comments
Post a Comment